6002-15-9

Basic information

• Product Name: 1-Phenyl-1H-imidazole-2-carbaldehyde, 97%
• Synonyms: 1-Phenyl-1H-imidazole-2-carbaldehyde, 97%;1-PHENYL-1H-IMIDAZOLE-2-CARBOXALDEHYDE
• CAS NO: 6002-15-9
• Molecular Formula: C₁₀H₈N₂O
• Molecular Weight: 172
• Mol File: 6002-15-9.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-Phenyl-1H-imidazole-2-carbaldehyde, 97%(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Phenyl-1H-imidazole-2-carbaldehyde, 97%(6002-15-9)
• EPA Substance Registry System: 1-Phenyl-1H-imidazole-2-carbaldehyde, 97%(6002-15-9)

Safety Data

• Hazardous Substances Data: 6002-15-9(Hazardous Substances Data)

Usage

General Description

1-Phenyl-1H-imidazole-2-carbaldehyde is a chemical compound with a purity of 97%. It is a white to off-white solid with a molecular formula of C10H8N2O and a molecular weight of 172.18 g/mol. 1-Phenyl-1H-imidazole-2-carbaldehyde, 97% is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is also utilized in the production of dyes, pigments, and other industrial substances. With its high purity level, 1-Phenyl-1H-imidazole-2-carbaldehyde is suitable for a wide range of research and manufacturing applications. It should be handled and stored in accordance with standard chemical safety practices and regulations.

Upstream product

• 7164-98-9 1-phenylimidazole 
• 109-94-4 formic acid ethyl ester 
• 108-86-1 bromobenzene 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 123125-04-2 1-Phenyl-4'-trifluoromethyl-1H,1'H-[2,2']biimidazolyl 
• 169378-05-6 1-phenyl-2-(1,3-dioxolan-2-yl)imidazole 
• 32545-00-9 2-ethynyl-1-phenyl-1H-imidazole 
• 1021865-02-0 C₁₈H₁₆N₂ 

Relevant articles and documents

Optimization of diarylpentadienones as chemotherapeutics for prostate cancer

Our earlier studies indicate that (1E,4E)-1,5-bis(1-alkyl-1H-imidazol-2-yl)penta-1,4-diene-3-ones and (1E,4E)-1,5-bis(1-alkyl-1H-benzo[d]imidazol-2-yl)penta-1,4-diene-3-ones exhibit up to 121-fold greater antiproliferative potency than curcumin in human p

Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria

Two different series of N-substituted imidazolium oximes and their monoquaternary salts were synthesized and biologically tested with respect to their ability to inhibit growth a diverse panel of antibiotic susceptible Gram-positive and antibiotic resistant Gram-negative bacteria as well fungal strains. The newly synthesized compounds were analyzed by spectral studies to confirm their structure. The preliminary results showed that all compounds tested possess promising antimicrobial potential against both susceptible Gram-positive and antibiotic resistant Gram-negative isolates, exhibiting a wide range of MIC values from 0.14 to 100.0 μg/mL. The structure-activity relationship demonstrates that the p-methylphenyl and p-fluorophenyl groups in monoquaternary salts 6 and 7 attached directly to the imidazolium ring could be essential for observed remarkable inhibitory profiles against clinically important pathogens Pseudomonas aeruginosa (MIC = 0.14 μg/mL) and Klebsiella pneumoniae (MIC = 1.56 μg/mL). Furthermore, the broth microdilution assay was then used to investigate the antiresistance efficacy of compound 7 against fourteen extended-spectrum β-lactamase (ESBL)-producing strains in comparison to eight clinically relevant antibiotics. Compound 7 exhibited a remarkable antiresistance profiles ranging between 0.39 and 12.50 μg/mL against all of ESBL-producing strains, which leads to the suggestion that may be interesting candidate for development of new antimicrobials to combat multidrug resistant Gram-negative bacteria.

Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof

Substitutued heterocyclylisoquinolinium salts, pharmaceutical compositions containing them and methods for the treatment or prevention of neurodegenerative disorders or neurotoxic injuries utilizing them.